Obsidian Therapeutics Announces Leadership Transition and Appoints Paul K. Wotton, Ph.D., as Chief Executive Officer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 18, 2019--Obsidian Therapeutics, a biotechnology company developing cell-based therapeutics with controllable operating systems, today announ…
